Spotlight on Clinical Outcomes Research: COS's Stellar Presentations at ISPOR EU Barcelona

In the rapidly advancing realm of Clinical Outcomes Research, forums like the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) EU Barcelona provide a unique platform for professionals to present, discuss, and collaborate on contemporary research and methodologies. Clinical Outcomes Solutions (COS) has always been at the forefront of such innovations, and our recent contributions at ISPOR EU Barcelona further solidify this stance.


A Dive into the Presentations by COS

Our team delivered engaging presentations at the event, shedding light on various facets of Patient-Reported Outcome (PRO) measures. Here's a snapshot of our team's endeavors:

  1. Navigating the Terrain of Multinational Trials
    Presenters: Crawford B, Kim HR, Newton L, Symonds T
    Date: 12 November 2018; 11:15–12:15
    This workshop illuminated the challenges and potential solutions in developing PRO instruments tailored for multinational clinical trials.

  2. Digital Transitions in PRO Collection
    Two distinct yet complementary presentations delved into the feasibility of using personal versus provisioned devices for gathering PROs from COPD patients.

    • Quantitative findings presented by Hudgens S, Newton L, and team on 13 November 2018.

    • Qualitative interview findings by Newton L, Knight-West O, and colleagues on 13 November 2018.

  3. Innovative Data Collection in Ulcerative Colitis Research
    Presenters: Randall JA, Codispoti N, and team
    Date: 13 November 2018
    This presentation showcased how patient collages can enhance qualitative interviews, providing richer insights into the experiences of those diagnosed with ulcerative colitis.

  4. Methodologies for Interpreting Multi-Item PROs
    Presenters: Hudgens S, Floden L, and team
    Date: 13 November 2018
    This poster dived into a novel longitudinal, item-level analysis methodology that enhances the interpretability of multi-item patient-reported outcomes.

  5. Skin Symptom Evaluation in Cutaneous T-Cell Lymphoma Patients
    Presenters: Hudgens S, Floden L, and team
    Date: 14 November 2018
    An in-depth evaluation was presented on the impact of treatments on disease-specific skin symptoms using the Skindex-29 measure.


A Commitment to Push Boundaries

The range and depth of these presentations underscore COS's commitment to driving excellence in Clinical Outcomes Research. We consistently push boundaries, exploring innovative methodologies, and ensuring patient-centricity is at the core of all outcomes research.

For professionals, researchers, and stakeholders in the domain, we invite you to dive deeper into our presentations and join us in our mission to shape patient-centered outcomes research for the better.

Stay connected for further insights, updates, and pioneering contributions from the world of Clinical Outcomes Research.

Previous
Previous

Optimizing Patient-Reported Outcome Measures in Clinical Practice: A Guide to Excellence

Next
Next

Louise Newton's Research Recognized: Awarded JPRO Article of the Year